| Bioactivity | Laninamivir TFA (R 125489 TFA) is an antiviral compound with inhibitory and prophylactic activity against influenza A and B viruses. Laninamivir TFA is a long-acting neuraminidase inhibitor administered by nasal inhalation. Laninamivir TFA has shown good safety and efficacy in the inhibition of influenza viruses[1]. |
| CAS | 203120-18-7 |
| Formula | C15H23F3N4O9 |
| Molar Mass | 460.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vavricka CJ, et al. Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog. 2011 Oct;7(10):e1002249. [2]. Antiviral Drugs in Influenza |
Laninamivir TFA
CAS: 203120-18-7 F: C15H23F3N4O9 W: 460.36
Laninamivir TFA (R 125489 TFA) is an antiviral compound with inhibitory and prophylactic activity against influenza A an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.